- Issuer ticker
-
BFNH
- Reported as of
-
17 Oct 2023
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
18 Oct 2023, 16:16:25 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Merle Ferguson
Key filing fact
Merle Ferguson filed Form 4 for BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) on 18 Oct 2023.
Key facts
- This page summarizes Merle Ferguson's Form 4 filing for BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 18 Oct 2023, 16:16.
Change
- Previous filing in this sequence was filed on 04 Oct 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BFNH
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- -1,470,000
- Change %
- -8.9%
- Price
-
$0.000000
- Shares after
- 15,000,000
- Date
- 17 Oct 2023
- Ownership
- Shares Held in Private Company
- Footnotes
- F1
BFNH
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- +1,470,000
- Change %
- +9.8%
- Price
-
$0.000000
- Shares after
- 16,470,000
- Date
- 17 Oct 2023
- Ownership
- Direct
BFNH
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- +1,400,000
- Change %
- +8.5%
- Price
-
$0.000000
- Shares after
- 17,870,000
- Date
- 18 Oct 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote